ATC Group: R07AX01 Nitric oxide

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of R07AX01 in the ATC hierarchy

Level Code Title
1 R Respiratory system
2 R07 Other respiratory system products
3 R07A Other respiratory system products
4 R07AX Other respiratory system products
5 R07AX01 Nitric oxide

Active ingredients in R07AX01

Active Ingredient

Nitric oxide is a compound produced by many cells of the body. It relaxes vascular smooth muscle by binding to the haeme moiety of cytosolic guanylate cyclase. When inhaled, nitric oxide produces selective pulmonary vasodilation.

Related product monographs

Document Type Information Source  
 INOMAX Inhalation gas MPI, EU: SmPC European Medicines Agency (EU)
 KINOX Inhalation gas MPI, CA: SPM Health Products and Food Branch (CA)
 NEOPHYR Medicinal gas, compressed MPI, EU: SmPC Health Products Regulatory Authority (IE)
 NOXIVENT 101 Inhalation gas MPI, US: SPL/PLR FDA, National Drug Code (US)

United States medicines

Medicines classified under this ATC code globally

Canada (CA)

Croatia (HR)

Cyprus (CY)

Ecuador (EC)

Estonia (EE)

Finland (FI)

France (FR)

Ireland (IE)

Italy (IT)

Japan (JP)

Lithuania (LT)

Poland (PL)

Romania (RO)

Spain (ES)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.